172 related articles for article (PubMed ID: 28093879)
1. Valproate-induced encephalopathy in a comorbid elderly woman.
Gandolfo F; Parodi MN; Corsini GP; Odetti P; Serafini G; Monacelli F
Psychogeriatrics; 2017 May; 17(3):208-209. PubMed ID: 28093879
[No Abstract] [Full Text] [Related]
2. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
[TBL] [Abstract][Full Text] [Related]
3. A case of valproate-induced hyperammonaemic encephalopathy.
Lucie O; Nazir F; Spilg E
Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
[TBL] [Abstract][Full Text] [Related]
4. A case of valproate-induced encephalopathy.
Hong L; Schutz J; Nance M
Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
[No Abstract] [Full Text] [Related]
5. Lesson of the month 1: Sodium valproate-induced encephalopathy.
Camilleri L
Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
[TBL] [Abstract][Full Text] [Related]
6. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
Sunkavalli KK; Iqbal FM; Singh B; Koneru J
Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
[TBL] [Abstract][Full Text] [Related]
7. Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy.
Baumgartner J; Hoeflich A; Hinterbuchinger B; Fellinger M; Graf I; Friedrich F; Frey R; Mossaheb N
Am J Psychiatry; 2019 Nov; 176(11):900-903. PubMed ID: 31672038
[No Abstract] [Full Text] [Related]
8. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
Panikkar GP; Gilman SM
J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
[No Abstract] [Full Text] [Related]
9. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
Al-sharefi A; Bilous R
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
[TBL] [Abstract][Full Text] [Related]
10. [Valproate can induce reversible encephalopathy].
Prakash S; Harbo T; Christensen J
Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
[TBL] [Abstract][Full Text] [Related]
11. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
[TBL] [Abstract][Full Text] [Related]
12. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
[TBL] [Abstract][Full Text] [Related]
13. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
[TBL] [Abstract][Full Text] [Related]
14. Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.
Sarlon J; Hess E; Krasnianski A
J Neuropsychiatry Clin Neurosci; 2013; 25(3):E69-70. PubMed ID: 24026753
[No Abstract] [Full Text] [Related]
15. Valproate Induced Hyperammonemic Encephalopathy.
Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
[TBL] [Abstract][Full Text] [Related]
16. A case of hyperammonaemic encephalopathy due to valproic acid.
Prins MC; van Meijel JJ
Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced encephalopathy.
Rehman A; Zafar S
J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
[TBL] [Abstract][Full Text] [Related]
18. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
[No Abstract] [Full Text] [Related]
19. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
Izadi Firouzabadi L; Geer K; Mead P;
Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
[No Abstract] [Full Text] [Related]
20. Valproate-induced hyperammonemia as a cause of altered mental status.
Feil D; Chuang K; Sultzer DL
Am J Geriatr Psychiatry; 2002; 10(4):476-8. PubMed ID: 12095907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
